W. R. Wayne Martin
#186,518
Most Influential Person Now
W. R. Wayne Martin's AcademicInfluence.com Rankings
W. R. Wayne Martinphilosophy Degrees
Philosophy
#12086
World Rank
#16736
Historical Rank
Logic
#8907
World Rank
#11210
Historical Rank
W. R. Wayne Martinbiology Degrees
Biology
#15694
World Rank
#19734
Historical Rank
Neuroscience
#2848
World Rank
#2925
Historical Rank
Download Badge
Philosophy Biology
Why Is W. R. Wayne Martin Influential?
(Suggest an Edit or Addition)W. R. Wayne Martin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. (1983) (1060)
- Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography. (1984) (591)
- A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study. (2002) (547)
- Midbrain iron content in early Parkinson disease (2008) (350)
- Practice parameter: Initiation of treatment for Parkinson’s disease: An evidence-based review (2002) (280)
- A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease (2006) (224)
- A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease (2007) (204)
- Cerebral Blood Volume Measured with Inhaled C15O and Positron Emission Tomography (1987) (199)
- Tolcapone improves motor function in parkinsonian patients with the"wearing-off" phenomenon: A double-blind, placebo-controlled, multicenter trial (1997) (197)
- Influence of lamotrigine on progression of early Huntington disease (1999) (144)
- Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease (2008) (140)
- Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease. (2007) (131)
- Extracranial‐intracranial bypass surgery (1984) (123)
- Cortical glucose metabolism in Huntington's disease (1992) (105)
- Supplement 4: Canadian Guidelines on Parkinson's Disease (2012) (100)
- Evolution of deep gray matter volume across the human lifespan (2017) (95)
- A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease (2017) (92)
- Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. (2006) (86)
- Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle (1995) (83)
- Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease (2008) (71)
- Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study. (2008) (67)
- The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography. (1991) (60)
- A randomized, controlled trial of remacemide for motor fluctuations in Parkinson’s disease (2001) (54)
- Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in Lytico-Bodig. The amyotrophic lateral sclerosis-parkinsonism-dementia complex of Guam. (1990) (54)
- Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. (2016) (54)
- Coexistence of Huntington’s disease and amyotrophic lateral sclerosis: a clinicopathologic study (2012) (48)
- Longitudinal midbrain changes in early Parkinson's disease: iron content estimated from R2*/MRI. (2015) (47)
- Daytime somnolence in patients with Parkinson's disease. (2001) (46)
- The FDG/PET Methodology for Early Detection of Disease Onset: A Statistical Model (1991) (43)
- Estimation of the iron concentration in excised gray matter by means of proton relaxation measurements (1996) (37)
- Increased Basal Ganglia Iron in Striatonigral Degeneration: In Vivo Estimation with Magnetic Resonance (1998) (35)
- Positron emission tomography in progressive supranuclear palsy. (1991) (34)
- Subthalamic nucleus stimulation in Parkinson disease (2008) (31)
- Quantitative estimation of regional brain iron with magnetic resonance imaging. (2009) (30)
- Is brain lactate increased in Huntington's disease? (2007) (29)
- Basal ganglia activation in Parkinson's disease. (2006) (26)
- Pathologic correlates of supranuclear gaze palsy with parkinsonism. (2017) (25)
- Cerebral blood volume, blood flow, and oxygen metabolism in cerebral ischaemia and subarachnoid haemorrhage: An in-vivo study using positron emission tomography (2005) (24)
- Is Levodopa Response a Valid Indicator of Parkinson's Disease? (2020) (21)
- Assessment of fetal tissue transplantation in Parkinson's disease (1994) (20)
- Cerebral Glucose and Dopa Metabolism in Movement Disorders (1987) (15)
- Parkinsonian syndromes and differential diagnosis (2002) (14)
- Positron emission tomography in Shy‐Drager syndrome (1990) (13)
- Positron Emission Tomography in Movement Disorders (1985) (12)
- Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease (2015) (12)
- The Prevalence of Motor Neurone Disease in the Province of Alberta (1999) (10)
- Incidence of hip fracture in Parkinson disease: a population-based study in British Columbia, Canada (2010) (6)
- An Aging Effect in Striatal Fluorodopa Uptake? Large versus Small Rois (1994) (6)
- Magnetic resonance imaging and spectroscopy in Parkinson's disease. (2001) (6)
- Intact presupplementary motor area function in early, untreated Parkinson's disease (2008) (5)
- Tolcapone improves motor function in parkinsonian patients with the"wearing-off" phenomenon (1998) (5)
- Different β-amyloid binding patterns in Alzheimer and Parkinson diseases (2013) (4)
- Parkinson's disease: positron emission tomographic studies. (1989) (4)
- The contribution of PET scanning to understanding metabolism and drug actions in the basal ganglia. (1987) (2)
- Positron Emission Tomography and Autoradiography (1986) (1)
- Positron Emission Tomography (1986) (1)
- biomarker of disease status Midbrain iron content in early Parkinson disease : A potential (2008) (1)
- Clinical Features of Parkinson Disease (2010) (1)
- Measurement of Regional Cerebral Oxygen Consumption and Blood Flow in Man (1983) (1)
- Appendix A : Parkinson Disease FAQ Sheet (2010) (1)
- Poster — Thur Eve — 03: Application of the non‐negative matrix factorization technique to [11C]‐DTBZ dynamic PET data for the early detection of Parkinson's disease (2014) (1)
- P1.176 Incidence of hip fracture in Parkinson disease: a population-based study in British Columbia, Canada (2009) (1)
- SU‐E‐I‐173: Factor Analysis with Prior Information Using Projected Gradient Method — Application to 11C‐DTBZ Dynamic PET Dataset for Early Detection of Parkinsonˈs Disease (2011) (0)
- Policy Considerations for Alberta (2010) (0)
- PO24-TH-02 Incidence and prevalence of Parkinson disease in Canadian seniors (2009) (0)
- Highlights of Current Research in Parkinson Disease (2010) (0)
- Current Approaches to the Management of Parkinson Disease (2010) (0)
- O.053 Quantitative estimation of regional brain iron with MRI (2009) (0)
- Disorders of the basal ganglia (1988) (0)
- Appendix B : Glossary of Terms (2010) (0)
- Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Parkinson ’ s Disease Structural vs Functional Changes (0)
- Clinical MR Neuroimaging: Physiological MR in neurodegenerative diseases (2009) (0)
- Application of the non-negative matrix factorization technique to [ 11 C ]-DTBZ dynamic PET data for the early detection of Parkinson ’ s disease (2014) (0)
- Positron Emission Tomography in Dementia (1991) (0)
- Neuroanatomical Changes in Parkinson’s Disease: Neuroimaging Evaluation of Pedunculopontine Nucleus (P2.002) (2014) (0)
- The Metabolism of the Human Brain Studied with Positron Emission Tomography (1985) (0)
- “Defiant and Rebellious” Behavior in a Canadian Teenager: Sarah’s Difficult Journey (2012) (0)
- Functional Imaging in Movement Disorders (1990) (0)
- emission tomography . Wilson ' s disease studied with positron The nigrostriatal dopaminergic pathway in (0)
- 1.019 DOPAMINE RESPONSIVE AND NON-RESPONSIVE GAIT PARAMETERS IN PARKINSON'S DISEASE (2012) (0)
- The Highs and Lows of Deep Brain Stimulation in Dystonia: The Story of a Canadian Boy (2012) (0)
- Notice of Redundant Publication: “Transdermal Rotigotine: Double-blind, Placebo-Controlled Trial in Parkinson Disease” (Arch Neurol. 2007;64[5]:676-682)—Reply (2007) (0)
- Imaging the Basal Ganglia (1989) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With W. R. Wayne Martin?
W. R. Wayne Martin is affiliated with the following schools:
